I am honored to serve as a Key Opinion Leader (KOL) for AlphaFlo, a canine-specific amniotic allograft platform.

In this role, I provide independent, real-world clinical feedback, participate in continuing education and professional discussions, and contribute to the development of best-practice guidance for the responsible clinical integration of tissue-supportive biologic therapies.

AlphaFlo Canine Allograft is utilized as an adjunctive, tissue-supportive modality across a range of clinical contexts, with an emphasis on safety, appropriate case selection, and integration alongside established standards of care.